Covered recipient · General Payments record
ELIZABETH PRINCE-COLEMAN
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$1,661.47
- Reported across 88 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $199.79 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Averitas Pharma Inc. | $27.24 | 1 |
| Merz Pharmaceuticals, LLC | $23.07 | 1 |
| EISAI INC. | $21.93 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.02 | 1 |
| Teva Pharmaceuticals USA, Inc. | $20.53 | 1 |
| ABBVIE INC. | $19.57 | 1 |
| Ipsen Biopharmaceuticals, Inc | $17.98 | 1 |
| Neurocrine BioSciences, Inc. | $17.88 | 1 |
| Abbott Laboratories | $15.73 | 1 |
| Neurelis, Inc. | $14.84 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $15.73 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124984894 | CMS |
| ABBVIE INC. | $19.57 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108041558 | CMS |
| Averitas Pharma Inc. | $27.24 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133467556 | CMS |
| Eisai Inc. | $21.93 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110800663 | CMS |
| Ipsen Biopharmaceuticals, Inc | $17.98 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091977691 | CMS |
| Merz Pharmaceuticals, LLC | $23.07 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137957373 | CMS |
| Neurelis, Inc. | $14.84 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145669358 | CMS |
| Neurocrine Biosciences, Inc. | $17.88 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150990580 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.02 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137810236 | CMS |
| Teva Pharmaceuticals USA, Inc. | $20.53 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151709845 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.